PROM2
Basic information
Region (hg38): 2:95274449-95291308
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PROM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 72 | 77 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 72 | 6 | 1 |
Variants in PROM2
This is a list of pathogenic ClinVar variants found in the PROM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-95274662-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
2-95274727-C-T | not specified | Uncertain significance (Dec 03, 2024) | ||
2-95274736-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
2-95274752-C-T | not specified | Uncertain significance (Sep 26, 2024) | ||
2-95274758-G-T | not specified | Uncertain significance (Nov 15, 2024) | ||
2-95274787-C-A | not specified | Uncertain significance (Oct 25, 2024) | ||
2-95274800-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
2-95275501-G-T | not specified | Uncertain significance (May 10, 2024) | ||
2-95275502-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
2-95275936-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
2-95275937-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
2-95276005-G-T | not specified | Uncertain significance (Jul 30, 2024) | ||
2-95276036-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
2-95276051-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
2-95276077-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
2-95276092-G-T | not specified | Uncertain significance (Dec 28, 2022) | ||
2-95276262-G-A | not specified | Likely benign (Mar 15, 2024) | ||
2-95276265-C-T | not specified | Uncertain significance (Jul 22, 2024) | ||
2-95276288-A-T | not specified | Uncertain significance (Nov 17, 2022) | ||
2-95276291-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
2-95276293-G-C | not specified | Uncertain significance (Dec 25, 2024) | ||
2-95276307-C-A | not specified | Uncertain significance (Sep 08, 2024) | ||
2-95276318-C-T | not specified | Uncertain significance (Jan 03, 2022) | ||
2-95276606-G-A | not specified | Uncertain significance (Sep 26, 2022) | ||
2-95276619-T-C | not specified | Uncertain significance (Feb 24, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PROM2 | protein_coding | protein_coding | ENST00000317620 | 23 | 16856 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.46e-15 | 0.964 | 125549 | 0 | 198 | 125747 | 0.000788 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.922 | 432 | 489 | 0.883 | 0.0000300 | 5303 |
Missense in Polyphen | 174 | 185.2 | 0.93952 | 2164 | ||
Synonymous | 0.146 | 215 | 218 | 0.987 | 0.0000139 | 1746 |
Loss of Function | 2.36 | 30 | 47.6 | 0.630 | 0.00000228 | 505 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00195 | 0.00169 |
Ashkenazi Jewish | 0.000522 | 0.000496 |
East Asian | 0.00645 | 0.00638 |
Finnish | 0.0000466 | 0.0000462 |
European (Non-Finnish) | 0.000271 | 0.000264 |
Middle Eastern | 0.00645 | 0.00638 |
South Asian | 0.000205 | 0.000196 |
Other | 0.000177 | 0.000163 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.0927
Intolerance Scores
- loftool
- 0.824
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.26
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- N
- hipred_score
- 0.313
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.287
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prom2
- Phenotype
- immune system phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- positive regulation of protein phosphorylation;positive regulation of cell projection organization;regulation of GTPase activity;negative regulation of pinocytosis;regulation of clathrin-dependent endocytosis;negative regulation of caveolin-mediated endocytosis
- Cellular component
- integral component of plasma membrane;microvillus;cilium;cell surface;basolateral plasma membrane;apical plasma membrane;cytoplasmic vesicle;microvillus membrane;cell projection;microspike;membrane raft;ciliary membrane;extracellular exosome;prominosome
- Molecular function
- cholesterol binding